Louisiana 2014 2014 Regular Session

Louisiana House Bill HB212 Comm Sub / Analysis

                    Page 1 of 1
Lebas (HB 212)	Act No. 40
Existing law provides for the designation of controlled dangerous substances into Schedules
I, II, III, IV, and V based upon the substances' potential for addiction and abuse.
New law adds 4-anilino-N-phenethyl-4-piperidine (ANPP) as an immediate precursor to
fentanyl to Schedule II.
New law adds perampanel, methasterone, and prostanozol to Schedule III.
New law adds lorcaserin and alfaxalone to Schedule IV.
Effective August 1, 2014.
(Amends R.S. 40:964(Schedule IV)(B)(1); Adds R.S. 40:964(Schedule II)(E)(3), (Schedule
III)(B)(15), (E)(29.1) and (53.1), (Schedule IV)(B)(1.5) and (Schedule IV)(D)(13))